Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.630
+0.012 (1.88%)
Dec 20, 2024, 4:00 PM EST - Market closed
Entero Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 3 | 5 | 18 | 29 | 28 | |
| Market Cap Growth | -71.30% | -44.22% | -71.77% | -38.97% | 6.51% | 29.74% | |
| Enterprise Value | 3 | -0 | 4 | 11 | 18 | 28 | |
| Last Close Price | 0.63 | 4.20 | 122.58 | 6069.01 | 40740.04 | 43680.04 | |
| Debt / Equity Ratio | 0.00 | 0.23 | 0.32 | -0.13 | -0.24 | 0.35 | |
| Quick Ratio | 0.02 | 1.18 | 0.59 | 0.67 | 0.43 | 0.66 | |
| Current Ratio | 5.34 | 1.58 | 1.37 | 0.77 | 0.51 | 0.80 | |
| Return on Equity (ROE) | -21.60% | -497.87% | - | - | -3305.91% | -333.90% | |
| Return on Assets (ROA) | -25.22% | -159.97% | -91.98% | -286.81% | -151.38% | -112.57% | |
| Return on Capital (ROIC) | -31.39% | -244.72% | - | - | -784.81% | -168.30% | |
| Buyback Yield / Dilution | -1324.34% | -836.57% | - | - | - | - | |
| Total Shareholder Return | -1324.34% | -836.57% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.